The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids – Part 2 of 3
In the United States, use of these combination inhalers is also not considered first-line therapy for asthma, according to Dr Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City. “Patients, however, are currently using these association inhalers”. If the asthma is moderate to severe, then a combination inhaler is appropriate who was not involved with either new study.
The reports were published in the March exit of the journal Lancet Respiratory Medicine. One study was funded by Italian pharmaceutical company Chiesi Farmaceutici, whose products include asthma medications. The multi-center European contemplation was led by Dr Klaus Rabe, a professor of pulmonary medicine at the University of Kiel, in Germany.
The study included more than 1700 patients with moderate asthma. Researchers found that participants using the single, society inhaler had significantly fewer severe asthma attacks and were seen at a hospital or urgent medical facility less than those patients using the two inhalers. Rabe and colleagues wrote that although drugs like Symbicort (the set budesonide/formoterol combination used in the study) can be more expensive than separate inhalers, the ability to prevent asthma attacks and reduce hospital and emergency room visits may be cost-saving in the end.